Stem Cell Therapy International, Inc. Press Releases

• 07/14/10 AmStem Reports Positive Early Results From SteMixx™ Consumer Study
  
  
• 07/01/10 AmStem Completes $1 Million Bridge Financing To Drive Launch of Cosmeceutical Facial Cream Product SteMixx™
  
  
• 06/22/10 AmStem Announces Initial U.S. Study of Flagship Cosmeceutical Facial Cream Product SteMixx™
  
  
• 06/16/10 AmStem Finds Innovative New Ways to Use Cord Blood Stem Cells in Skin Care and Anti-Aging Products
  
  
• 06/09/10 AmStem Announces New Cosmeceutical Beauty and Hair Restoration Products
  
  
• 06/02/10 AmStem Announces Opening Of New Operational Headquarters In San Francisco
  
  
• 05/19/10 AmStem Corporation Retains Hawk Associates for Strategic Investor Relations
  
  
• 02/09/10 Dr. Hoon Han Elected Chairman Of The Board Of Stem Cell Therapy International
  
  
• 02/08/10 Histostem Participates In Successful Stem Cell Treatment For Acute Spinal Cord Injury In Dogs
  
  
• 02/01/10 Stem Cell Therapy International, Inc. Closes Merger With Histostem LTD.
  Merger Forms One Of The First Combined Pacific Rim And U.S. Stem Cell Entities
  
  
• 01/12/10 Stem Cell Therapy Appoints New Board Member
  
  
• 12/29/09 Audit Integrity Accounting Governance Risk Overview for AMST
  note: Stock Symbol change from SCII
  
  
• 12/23/09 Stem Cell Therapy Announces That Merger Is Progressing On Schedule
  
  
• 12/15/09 Stem Cell Therapy Featured In The Rose Sheet
  Company Continues to Pursue Distribution Partners
  
  
• 12/01/09 Stem Cell Therapy International, Inc Signs Agreement With Histostem For Worldwide Distribution Of SteMixx Cosmetic Products Just Approved By The Korean FDA
  
  
• 11/05/09 Stem Cell Therapy International, Inc. And Histostem Korea Announce Providing Hematopoietic Stem Cells To Queen Mary Hospital, Hong Kong
  Histostem to Provide Hematopoietic Stem Cells to a Major Hong Kong Hospital for the Treatment of Leukemia
  
  
• 11/03/09 Stem Cell Therapy International, Inc. and Histostem Korea Announce $5 Million Financing Commitment
  Financing to Provide Resources for Ongoing Development of Stem Cell Products and Research Initiatives
  
  
• 10/28/09 Stem Cell Therapy International, Inc. Letter to Shareholders, Partners and Friends
  Stem Cell Therapy (AMST) was able to facilitate a settlement in a lingering lawsuit with terms that were favorable for shareholders; and more importantly, this settlement freed us to move forward with our planned reorganization and stock purchase agreement with Histostem Korea.
  note: Stock Symbol change from SCII
  
  
• 10/20/09 Stem Cell Therapy International, Inc. Announces E.U. Patent Awarded For Isolation Of Stem Cells From Live Media
  
  
• 10/08/09 Stem Cell Therapy International, Inc. Announces U.S. Patent Awarded For Isolation Of Stem Cells For Therapy
  
  
• 09/10/09 Stem Cell Therapy International, Inc. Announces Histostem Litigation Settlement
  
  
• 06/25/09 Stem Cell Therapy International, Inc. Announces the Distribution of Histostem Products
  
  
• 04/02/09 Stem Cell Therapy International, Inc. (Soon To Be “AMSTEM”) Announces New Stem Cell Product
  
  
• 03/31/09 Stem Cell Therapy International, Inc. (Soon To Be “AMSTEM”) Ready To Replicate Histostem's Success in South Korea On An International Scale
  
  
• 03/23/09 United States Securities and Exchange Commission - Form 8K
  
  
• 03/17/09 Stem Cell Therapy International, Inc. Announces Bridge Financing Obtained
  
  

Histostem Press Releases

• 07/07/05 South Korean medical firm offers stem cell treatment to foreigners
  
  
• 03/22/05 AFP ‘Seoul blood bank freezes assets for breakthrough cell therapy’
  
  
• 11/26/04 The Korea Times ‘Korean Scientists Succeeded in Stem Cell Therapy’